<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02321670</url>
  </required_header>
  <id_info>
    <org_study_id>OUS-URO-SUPS</org_study_id>
    <nct_id>NCT02321670</nct_id>
  </id_info>
  <brief_title>Scandinavian Urethroplasty Study</brief_title>
  <acronym>SUPS</acronym>
  <official_title>Scandinavian Urethroplasty Study. A Multicentre, Prospective, Randomized Study Comparing Bulbar Urethroplasty With Excision and Primary Anastomosis or With an Onlay Grafting Procedure Using Buccal Mucosa.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Örebro County</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multicentre, prospective, randomized study comparing bulbar urethroplasty with excision and
      primary anastomosis or with an onlay grafting procedure using buccal mucosa.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a prospective, randomized study to compare two common techniques of
      urethroplasty used to treat bulbar urethral strictures. One technique is excision of the
      stricture and end-to-end anastomosis of the urethra. The other technique is an onlay grafting
      procedure with buccal mucosa where the corpus spongiosum is not divided. The study is
      designed to compare complications of sexual and penile function, and is not powered to
      compare the success rates of the two techniques. The primary endpoint will be degree of
      erectile dysfunction and penile complications. The secondary endpoint will be restricturing
      leading to reoperation, and other complications.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of erectile dysfunction after surgery</measure>
    <time_frame>up to one year</time_frame>
    <description>Measured by changes in IIEF-5</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Penile complications</measure>
    <time_frame>up to one year</time_frame>
    <description>Measured by questionnaire made for this study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of failure within the follow up period</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of complications</measure>
    <time_frame>From operation to one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Urethral Stricture</condition>
  <arm_group>
    <arm_group_label>End-to-end</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Excision of the stricture and end-to-end anastomosis of the urethra.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Incision of the stricture and grafting procedure with buccal mucosa where the corpus spongiosum is not divided.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>End-to-end</intervention_name>
    <description>Excision of the stricture and end-to-end anastomosis of the urethra.</description>
    <arm_group_label>End-to-end</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Graft</intervention_name>
    <description>Incision of stricture and grafting procedure with buccal mucosa where the corpus spongiosum is not divided</description>
    <arm_group_label>Graft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patient with bulbar urethral stricture, length estimated by urethrography or endoscopy ≤ 2
        cm

        Patient is able and willing to sign informed consent

        Patient is able and willing to complete all study requirements

        Exclusion Criteria:

        Previous open urethroplasty

        Previous hypospadia surgery

        Previous surgery for congenital curvature or Mb Peyronie

        Previous pelvic irradiation therapy

        Known grave psychiatric disorder

        Haemophilia or other clotting disorders that cause bleeding diathesis

        Use of medication to increase erectile function, such as PDE5-inhibitors and intracavernous
        injections, during the study

        Any condition or situation, which, in the investigator's opinion, puts the patient at
        significant risk, could confound the study results, or may interfere significantly with the
        patient's participation in the study
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Schultz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consultant</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ole Jacob Nilsen, MD</last_name>
    <phone>+47 23070000</phone>
    <email>ojnilsen@ous-hf.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexander Schultz, MD</last_name>
    <phone>+47 23070000</phone>
    <email>aschultz@ous-hf.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jukka Sairanen, MD, PhD</last_name>
      <phone>+358504271039</phone>
      <email>jukka.sairanen@hus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital, Dept of Urology</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Øyvind Modalsli, MD</last_name>
      <phone>+4722894000</phone>
      <email>oeymod@ous-hf.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital, Dept of Urology</name>
      <address>
        <city>Gothenburg</city>
        <zip>41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klas Lindqvist, MD, PhD</last_name>
      <phone>+46313429027</phone>
      <email>klas.lindqvist@vgregion.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital, Dept of Urology</name>
      <address>
        <city>Örebro</city>
        <zip>70185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beata Persson, MD</last_name>
      <phone>+46196011106</phone>
      <email>beata.persson@regionorebrolan.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Norway</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2014</study_first_submitted>
  <study_first_submitted_qc>December 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2014</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Ole Jacob Nilsen</investigator_full_name>
    <investigator_title>Consultant, Head of section</investigator_title>
  </responsible_party>
  <keyword>operative technique</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urethral Stricture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

